Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2025-12-25 @ 9:28 PM
NCT ID: NCT02958956
Description: Due to the observational nature of study individual adverse events (AEs) were not planned to be collected and reported.
Frequency Threshold: 0
Time Frame: None
Study: NCT02958956
Study Brief: Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Ever User of Pioglitazone Ever user of pioglitazone was defined as having filled 2 prescriptions for the drug within a 6-month period. None None 0 0 0 0 View
Never User of Pioglitazone Never user of pioglitazone, which included participants receiving no diabetes medications, with fewer than 2 pioglitazone prescription fills in a 6-month period, and with use of diabetes medications other than pioglitazone. None None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):